PART TWO
Diagnostic Cytology
22.
Minnassian H, Schinella R, Reilly JC.
Polyomavirus in the urine: Follow-up
study.
Diagn Cytopathol
1994;10:209-211.
23.
Crabbe JGS. "Comet" or "decoy" cells
found in urinary sediment smears.
Acta
Cytol
1971;15:303-305.
24.
Highman W, Wilson E. Urine cytology
in patients with calculi.
J Clin Pathol
1982;35:350-356.
25.
Rubben H, Hering F, Dahm HH, et al.
Value of exfoliative urinary cytology for
differentiation between uric acid stone
and tumor of upper urinary tract.
Urol-
ogy
1982;22:571-573.
26.
Jemal A, Siegel R, Ward E, et al.
Cancer statistics, 2007.
CA Cancer J Clin
2007;57:43-66.
27.
Eble JN, Sauter G, Epstein JI, eds.
Pathol-
ogy and Genetics of Tumours of the Urinary
System and Male Genital Organs. World
Health Organization Classification of
Tumours.
Lyon: IARC Press, 2003.
28.
Wolinska Wh, Melamed MR, Klein FA.
Cytology of bladder papilloma.
Acta
Cytol
1985;29:817-822.
29.
Kannan V, Bose S. Low grade transi-
tional cell carcinoma and instrument
artifact. A challenge in urinary cytology.
Acta Cytol
1993;37:899-902.
30.
Boon ME, Kurver PHJ, Baak JPA, et al.
Morphometric differences between
urothelial cells in voided urine of
patients with grade I and grade II bladder
tumours.
J Clin Pathol
1981;34:612-615.
31.
Raab SS, Lenel JC, Cohen MB. Low
grade transitional cell carcinoma of the
bladder. Cytologic diagnosis by key fea-
tures as identified by logistic regression
analysis.
Cancer
1994;74:1621-1626.
32.
Farrow GM. Pathology of carci-
noma in situ of the urinary bladder
and related lesions.
J Cell Biochem
1992;16I(Suppl):39-43.
33.
Melamed MR, Koss LG, Ricci A, et al.
Cytohistological observations on devel-
oping carcinoma of the urinary bladder
in man.
Cancer
1960;13:67-74.
34.
Koss LG, Tiamson EM, Robbins MD.
Mapping of cancerous and precancerous
bladder changes.
JAMA
1974;227:281-285.
35.
Farrow GM, Utz DC, Rife CC. Morpholog-
ical and clinical observations of patients
with early bladder cancer treated with
total cystectomy.
Cancer
1976;36:2495.
36.
Boon ME, Blomjous CEM, Zwartendijk
J, et al. Carcinoma in situ of the urinary
bladder: Clinical presentation, cytologic
pattern and stromal changes.
Acta Cytol
1986;30:360-366.
37.
Kern WH. The grade and patho-
logic stage of bladder cancer.
Cancer
1984;53:1185-1189.
38.
Kotliar SN, Wood CG, Shaeffer AJ, et al.
Transitional cell carcinoma exhibit-
ing clear cell features. A differential
diagnosis for clear cell adenocarcinoma
of the urinary tract.
Arch Pathol Lab Med
1995;119:79-81.
39.
Newman LH, Tannenbaum M, Droller
MJ. Muscle-invasive bladder cancer: Does
it arise de novo or from preexisting super-
ficial disease:
Urology
1988;32:58-62.
40.
Wheeless LL, Badalament RA, De Vere
White RW, et al. Consensus review of the
clinical utility of DNA cytometry in blad-
der cancer.
Cytometry
1993;14:478-481.
41.
Trillo AA, Kuchler LL, Wood AC, et al.
Adenocarcinoma of the urinary bladder:
Histologic, cytologic and ultrastructural
features in a case.
Acta Cytol
1981;25:
285-290.
42.
Mauri ME, Bonzanini M, Luciani L, et
al. Renal collecting duct carcinoma.
Report of a case with urinary cytologic
findings.
Acta Cytol
1994;38:755-758.
43.
Ordonez NG, Khorsand J, Ayala AG, et al.
Oat cell carcinoma of the urinary tract: An
immunohistochemical and electron micro-
scopy study.
Cancer
1986;58:2519-2525.
44.
Peven DR, Hidvegi DF. Clear-cell adeno-
carcinoma of the female urethra.
Acta
Cytol
1985;29:142-146.
45.
Wolinska WH, Melamed MR, Schell-
hammer PF, et al. Urethral cytology
following cystectomy for bladder carci-
noma.
Am J Surg Pathol
1977;1:225-234.
46.
Highman WJ. Transitional carcinoma of
the upper urinary tract: A histological
and cytopathological study.
J Clin Pathol
1986;39:297-306.
47.
Bagley DH, Rivas D. Upper urinary tract
filling defects: flexible ureteroscopic
diagnosis.
J Urol
1990;143:1196-1200.
48.
Low RK, Moran ME, Anderson KR. Ure-
teroscopic cytologic diagnosis of upper
tract lesions.
J Endourol
1993;7(4):311-314.
49.
Keeley FX, Kulp DA, Bibbo M, et al.
Diagnostic accuracy of ureteroscopic
biopsy in upper tract transitional cell
carcinoma.
J Urol
1997;157:33-37.
50.
Tawfiek E, Bibbo M, Bagley DH. Uretero-
scopic biopsy: Technique and specimen
preparation.
Urology
1997;50:117-119.
51.
Minimo C, Bagley D, Bibbo M. The role
of computed quantitation of immuno-
histochemical staining of p53 protein
in grading upper urinary tract urothelial
lesions.
J Urol Pathol
1996;4:261-271.
52.
Minimo C, Tawfiek ER, Bagley DH, et
al. Grading of upper urinary tract transi-
tional cell carcinoma by computed DNA
content and p53 expression.
Urology
1997;50:869-874.
53.
Keeley FX, Bibbo M, Mccue P, et al. Use
of P53 in the diagnosis of upper-tract
transitional cell carcinoma.
Urology
1997;49:181-186.
54.
Weaver EJ, Mccue PA, Bibbo M, et al.
Expression of cytokeratin 20 and CD44
protein in upper urinary tract transi-
tional cell carcinoma. Cytologic-his-
tologic correlation.
Analyt Quant Cytol
Histol
2001;23:339-344.
55.
Keeley FX, Bibbo M, Bagley DH. Ure-
teroscopic treatment and surveillance
of upper urinary tract transitional cell
carcinoma.
J Urol
1997;157:1560-1565.
56.
Piscioli F, Detassis C, Polla E, et al.
Cytologic presentation of renal adeno-
carcinoma in urinary sediment.
Acta
Cytol
1983;27:383-390.
57.
Sharifi R Shaw M, Ray V, et al. Evaluation
of cytologic techniques for diagnosis of
prostate cancer.
Urology
1983;21:417-420.
58.
Fanning CV, Staerkel GA, Sneige N, et
al. Spindling artifact of urothelial cells
in postlaser treatment urinary cytology.
Diagn Cytopathol
1993;9:279-281.
59.
Loveless KJ. The effects of radiation
upon the cytology of benign and malig-
nant bladder epithelium.
Acta Cytol
1973;17:355-360.
60.
Droller MJ, Erozan YS. Thiotepa effects
on urinary cytology in the interpreta-
tion of transitional cell cancer.
J Urol
1985;134:671-674.
61.
Cant JD, Murphy WM, Soloway MS.
Prognostic significance of urine cytology
in initial follow-up after intravesical
mitomycin C for superficial bladder
cancer.
Cancer
1986;57:2119-2122.
62.
Soloway MS, Perito PE. Superficial
bladder cancer: Diagnosis, surveil-
lance and treatment.
J Cell Biochem
1992;16I(Suppl):120-127.
63.
Bassi P, Milani C, Meneghini A, et al.
Clinical value of pathologic changes after
intravesical BCG therapy of superficial
bladder cancer.
Urology
1992;40:175-179.
64.
Wolinska WH, Melamed MR. Urinary
conduit cytology.
Cancer
1973;32:
1000-1006.
65.
Rosvanis TK, Rohner TJ, Abt AB.
Transitional cell carcinoma in an ileal
conduit.
Cancer
1989;63:1233-1236.
66.
Eggensperger D, Schweitzer S, Ferriol E,
et al. The utility of cytodiagnostic
urinalysis for monitoring renal allograft
injury.
Am J Nephrol
1988;8:27-34.
67.
Winkelmann M, Grabensee B, Pfitzer P.
Differential diagnosis of acute allograft
rejection and CMV infection in renal
transplantation by urinary cytology.
Pathol Res Pract
1985;180:161-168.
68.
Schumann GB, Weiss MA, Johnston JL.
Cytodifferentiation of urinary epithelial
fragments. Papillary transitional cell
carcinoma in a renal allograft recipient.
Acta Cytol
1981;25:302-306.
69.
Badalament RA, Hermansen DK, Kim-
mel M, et al. The sensitivity of bladder
wash flow cytometry, bladder wash
cytology, and voided cytology in the
detection of bladder carcinoma.
Cancer
1987;60:1423-1427.
70.
Badalament RA, Kimmel M, Gay H,
et al. The sensitivity of flow cytometry
compared with conventional cytology
in the detection of superficial bladder
carcinoma.
Cancer
1987;59:2078-2085.
71.
deVere White RW, Deitch AD, et al.
The predictive value of flow cytometric
information in the clinical management
of stage O (Ta) bladder cancer.
J Urol
1988;139:279-282.
72.
Al-Abadi H, Nagel R. Deoxyribonu-
cleic acid content and survival rates of
patients with transitional cell carcinoma
of the bladder.
J Urol
1994;151:37-42.
73.
Emerson RE, Liang C. Immunohisto-
chemical markers in the evaluation of
tumors of the urinary bladder. A review.
Anal Quant Cytol Histol
2005;27:301-316.
74.
Chichara Y, Sugano K, Kobayashi A, et al.
Loss of blood group A antigen expression
in bladder cancer caused by allelic loss
and/or methylation of the ABO gene.
Lab
Invest
2005;85(8):1051-1053.
75.
Lopez-Beltran A, Croghan GA, Croghan
I, et al. Prognostic factors in bladder can-
cer. Apathologic, immunohistochemical,
and DNA flow-cytometric study.
Am J
Clin Pathol
1994;102:109-114.
76.
Stampfer DS, Carpinito GA, Rodriguez-
Villanueva J, et al. Evaluation of NMP22
in the detection of transitional cell
carcinoma of the urinary tract.
J Urol
1996;156:1280-1285.
436
previous page 432 ComprehensiveCytopathology 1104p 2008 read online next page 434 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off